Amgen CEO tries to inject optimism into shareholder meeting
Thursday, May 8, 2008 - 12:14
in Mathematics & Economics
Kevin Sharer tells often-hostile investors that the company is off to a good start this year. The beleaguered chief executive of biotech giant Amgen Inc. confronted an often testy group of shareholders Wednesday, his first annual meeting with investors since the company's fortunes took a hard turn last summer.
Read the whole article
See latest science articles from LA Times - Science
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Related
- Carbon Disclosure Project: 'World's largest corporations seek clarity on climate change regulation'Sun, 21 Sep 2008, 21:28:41 EDT
- National survey finds information tech and business alignment a struggle for American companiesMon, 22 Sep 2008, 10:42:45 EDT
- New economic woes hit boomers, seniors hardestMon, 24 Nov 2008, 15:42:53 EST
- Private equity companies purchase nursing homes, but care does not sufferWed, 10 Sep 2008, 9:56:45 EDT
- Reducing CEOs' option-based compensation decreases risky investmentsWed, 22 Oct 2008, 17:56:53 EDT